E H Ortiz
Overview
Explore the profile of E H Ortiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosato-Siri M, Badaracco M, Ortiz E, Belforte N, Guardia Clausi M, Soto E, et al.
J Neurosci Res
. 2010 Feb;
88(8):1695-707.
PMID: 20127809
In rats, iron deficiency produces an alteration in myelin formation. However, there is limited information on the effects of this condition on oligodendroglial cell (OLGc) proliferation and maturation. In the...
2.
Perez M, Ortiz E, Roffe M, Soto E, Pasquini J
J Neurosci Res
. 2008 Dec;
87(15):3378-89.
PMID: 19115405
Mechanisms that regulate oligodendroglial cell (OLGc) differentiation are the focus of intensive research in the field of cellular and molecular neurobiology. We have previously shown that the addition of apotransferrin...
3.
Badaracco M, Ortiz E, Soto E, Connor J, Pasquini J
J Neurosci Res
. 2008 May;
86(12):2663-73.
PMID: 18459135
We have used a model of iron deficiency in the rat to analyze the effects of a disruption in iron availability on oligodendroglial cell (OLGc) maturation and myelinogenesis and to...
4.
Machiavelli M, Salum G, Perez J, Ortiz E, Romero A, Bologna F, et al.
Am J Clin Oncol
. 2004 Apr;
27(2):149-54.
PMID: 15057154
The purpose of this report is to evaluate the efficacy and toxicity (Tx) of a double modulation of 5-fluorouracil (5-FU) by trimetrexate (TMTX) and leucovorin (LV) in patients with advanced...
5.
Marta C, Ortiz E, Hallak M, Baron B, Guillou F, Zakin M, et al.
Dev Neurosci
. 2002 Oct;
24(2-3):242-51.
PMID: 12401964
Apotransferrin injected intracranially into young rats has been shown in our laboratories to induce an early differentiation of oligodendroglial cells and an increased deposition of myelin. The expression of some...
6.
Vallejo C, Perez J, Dominguez M, Leone B, Machiavelli M, Lacava J, et al.
Am J Clin Oncol
. 2000 Oct;
23(5):481-6.
PMID: 11039508
A phase II trial was performed to assess the efficacy and toxicity of a combination of ifosfamide (IFX), cisplatin (CDDP), and vinorelbine (VNB) as neoadjuvant chemotherapy (NAC) for untreated advanced...
7.
Biochemical modulation of 5-fluorouracil by methotrexate in patients with advanced gastric carcinoma
Perez J, Lacava J, Dominguez M, Rodriguez R, Barbieri M, Ortiz E, et al.
Am J Clin Oncol
. 1998 Oct;
21(5):452-7.
PMID: 9781598
A phase II trial was conducted to evaluate the efficacy and toxicity of a modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) (with leucovorin (LV) rescue) as first-line chemotherapy in patients...
8.
Perez J, Lacava J, Dominguez M, Rodriguez R, Barbieri M, Romero Acuna L, et al.
J Interferon Cytokine Res
. 1998 Sep;
18(8):565-9.
PMID: 9726437
A phase II trial was carried out by the Grupo Oncologico Cooperativo del Sur (G.O.C.S.) to assess the efficacy and toxicity of a biochemical modulation of 5-fluorouracil (5-FU) by i.v....
9.
Machiavelli M, Romero A, Perez J, Lacava J, Dominguez M, Rodriguez R, et al.
Cancer J Sci Am
. 1998 Apr;
4(2):125-31.
PMID: 9554929
Purpose: The prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy was assessed in patients with noninflammatory locally advanced breast carcinoma. Patients And...
10.
Romero A, Perez J, Cuevas M, Lacava J, Sabatini C, Dominguez M, et al.
Am J Clin Oncol
. 1998 Mar;
21(1):94-8.
PMID: 9499269
A phase II trial was performed to evaluate the efficacy and toxicity of a double modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) and L-leucovorin (L-LV) in patients with advanced recurrent...